19-18068499-C-T

Variant summary

Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting

The NM_005535.3(IL12RB1):​c.1217G>A​(p.Gly406Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000415 in 1,612,664 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G406V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00027 ( 0 hom., cov: 29)
Exomes 𝑓: 0.000018 ( 0 hom. )

Consequence

IL12RB1
NM_005535.3 missense

Scores

3
13

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 0.526
Variant links:
Genes affected
IL12RB1 (HGNC:5971): (interleukin 12 receptor subunit beta 1) The protein encoded by this gene is a type I transmembrane protein that belongs to the hemopoietin receptor superfamily. This protein binds to interleukine 12 (IL12) with a low affinity, and is thought to be a part of IL12 receptor complex. This protein forms a disulfide-linked oligomer, which is required for its IL12 binding activity. The coexpression of this and IL12RB2 proteins was shown to lead to the formation of high-affinity IL12 binding sites and reconstitution of IL12 dependent signaling. Mutations in this gene impair the development of interleukin-17-producing T lymphocytes and result in increased susceptibility to mycobacterial and Salmonella infections. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.04377082).
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00027 (41/151962) while in subpopulation AFR AF= 0.000989 (41/41442). AF 95% confidence interval is 0.000749. There are 0 homozygotes in gnomad4. There are 22 alleles in male gnomad4 subpopulation. Median coverage is 29. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
IL12RB1NM_005535.3 linkuse as main transcriptc.1217G>A p.Gly406Glu missense_variant 11/17 ENST00000593993.7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
IL12RB1ENST00000593993.7 linkuse as main transcriptc.1217G>A p.Gly406Glu missense_variant 11/171 NM_005535.3 P1P42701-1
IL12RB1ENST00000600835.6 linkuse as main transcriptc.1217G>A p.Gly406Glu missense_variant 12/181 P1P42701-1

Frequencies

GnomAD3 genomes
AF:
0.000270
AC:
41
AN:
151844
Hom.:
0
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.000992
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000682
AC:
17
AN:
249290
Hom.:
0
AF XY:
0.0000665
AC XY:
9
AN XY:
135240
show subpopulations
Gnomad AFR exome
AF:
0.00110
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000178
AC:
26
AN:
1460702
Hom.:
0
Cov.:
29
AF XY:
0.0000124
AC XY:
9
AN XY:
726714
show subpopulations
Gnomad4 AFR exome
AF:
0.000688
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000332
GnomAD4 genome
AF:
0.000270
AC:
41
AN:
151962
Hom.:
0
Cov.:
29
AF XY:
0.000296
AC XY:
22
AN XY:
74274
show subpopulations
Gnomad4 AFR
AF:
0.000989
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000157
Hom.:
0
Bravo
AF:
0.000246
ESP6500AA
AF:
0.000965
AC:
4
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000744
AC:
9

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpJan 09, 2024Variant summary: IL12RB1 c.1217G>A (p.Gly406Glu) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 6.8e-05 in 249290 control chromosomes. To our knowledge, no occurrence of c.1217G>A in individuals affected with Mendelian Susceptibility To Mycobacterial Diseases Due To Complete IL12RB1 Deficiency and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 1441039). Based on the evidence outlined above, the variant was classified as uncertain significance. -
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingInvitaeNov 08, 2022In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt IL12RB1 protein function. ClinVar contains an entry for this variant (Variation ID: 1441039). This variant has not been reported in the literature in individuals affected with IL12RB1-related conditions. This variant is present in population databases (rs199504990, gnomAD 0.1%). This sequence change replaces glycine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 406 of the IL12RB1 protein (p.Gly406Glu). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.20
CADD
Benign
13
DANN
Benign
0.94
DEOGEN2
Benign
0.23
T;T
Eigen
Benign
-0.68
Eigen_PC
Benign
-0.81
FATHMM_MKL
Benign
0.029
N
LIST_S2
Benign
0.51
.;T
M_CAP
Uncertain
0.15
D
MetaRNN
Benign
0.044
T;T
MetaSVM
Benign
-0.52
T
MutationAssessor
Uncertain
2.2
M;M
MutationTaster
Benign
1.0
N
PrimateAI
Benign
0.37
T
Sift4G
Uncertain
0.016
D;D
Polyphen
0.74
P;P
Vest4
0.27
MVP
0.93
MPC
0.19
ClinPred
0.043
T
GERP RS
2.0
Varity_R
0.099
gMVP
0.49

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs199504990; hg19: chr19-18179309; API